Colchicine, an anti-inflammatory drug traditionally used to treat gout and pericarditis, has shown efficacy in reducing cardiovascular risk by inhibiting microtubule polymerization and suppressing cytokine release, including IL-1β and IL-6 [79]. This evidence concerns the gene IL6 and pericarditis.